Stereotactic Reirradiation with CyberKnife for Locally Recurrent Prostate Cancer, Long-term Toxicity and Clinical Outcomes from a Monocentric Cohort
Francolini G, Carnevale MG, Di Cataldo V, Loi M, Detti B, Orsatti C, Caprara L, Bertini N, Lorenzetti V, Olmetto E, Becherini C, Visani L, Salvestrini V, Simontacchi G, Greto D, Bonomo P, Doro R, Masi L, Desideri I, Meattini I, Serni S, Livi L | Radiol Med | 2023
Intensity Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: Five-year Outcomes
Carrasquilla M, Sholklapper T, Pepin AN, Hodgins N, Lei S, Rashid A, Danner M, Zwart A, Bolanos G, Ayoob M, Yung T, Aghdam N, Collins B, Suy S, Kumar D, Hankins R, Kowalczyk K, Dawson N, Collins S | Front Oncol | 2023
Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B Study
Ratnakumaran R, Sasitharan A, Khan A, Mayet H, Mohajer J, Hinder V, Brand DH, Fullarton R, Loblaw A, Hall E, van As N, Tree AC; PACE trial investigators | Int J Radiat Oncol Biol Phys. | 2025
Late Radiation-related Lymphopenia After Prostate Stereotactic Body Radiation Therapy Plus or Minus Supplemental Pelvic Irradiation
Gaudian K, Koh MJ, Koh MJ, Jermain P, Khan I, Kallam D, Lee Z, Collins RR, Zwart Z, Danner M, Zwart A, Kumar D, Atkins MB, Suy S, Collins SP | Front Oncol. | 2024
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial
van As N, Yasar B, Griffin C, Patel J, Tree AC, Ostler P, van der Voet H, Ford D, Tolan S, Wells P, Mahmood R, Winkler M, Chan A, Thompson A, Ogden C, Naismith O, Pugh J, Manning G, Brown S, Burnett S, Hall E | Eur Urol. | 2024
Long-term Outcomes of Salvage Radiotherapy Using TomoTherapy With Image-guided Radiotherapy for Postoperative Prostate Cancer Patients
Mukai Y, Omura M, Minagawa Y, Mase M, Nishikawa Y, Miura I, Hata M | Cancer Diagn Progn | 2025
Salvage Radiosurgery After Brachytherapy for Locally Recurrent Prostate Cancer With Real-Time Adaptive Motion Management Using Previously Implanted Brachytherapy Seeds as Fiducial Markers
Yu JB, Grew DJ, Singh C, Sculley E, Jones A, Munbodh R. | Cureus Competition | 2025
Robotic Stereotactic Body Radiation Therapy for High-Risk Prostate Cancer: The Georgetown University Experience
Vaibhav Sharma, Tim Kearney, Zach Lee, Padraig Brennan Pilkington, Marielle Fis Loperena, Malika Danner, Alan L. Zwart, Deepak Kumar, Brian Collins, Michael Carrasquilla, Suy Simeng, Sean Collins | Cureus Competition | 2025
TomoTherapy With Synchrony Fiducial Tracking for Stereotactic Body Radiotherapy in Prostate Cancer: A Single-Center Experience on Toxicity
Lorella Lo Conte Jr., Vincenzo Iorio, Ida Rosalia Scognamiglio, Antonio Russo, Ersilia Donda, Alfonsina Pepe, Anna Viggiano, Ferdinando Francomacaro, Ivona Zlatkova, Caterina Muto. | Cureus Competition | 2025
Prostate Stereotactic Body Radiotherapy With Synchrony®-Based Fiducial Tracking on Radixact® X9
Acharya AV, Hunugundmath S, Deputy M, Nirhali A, Naik V, Gadhave S. | Cureus Competition | 2025
Real-Time Adaptive Motion Management in Prostate Stereotactic Body Radiation Therapy: Clinical and Dosimetric Analysis of 25 Patients
Goddard LC, Cabrera J, Tang J, Garg MK, Tome WA. | Cureus Competition | 2025
Use of Motion Management to Model Unmanaged Motion: Dosimetric Consequences of Unmanaged Prostate Motion Assessed Using Real-Time Radiotherapy Adaptation Data
Crowe SB, Walsh J, Rattray G, Chan P, Kairn T. | Cureus Competition | 2025
The Early Experience of Synchrony in Ultra-Hypofractionation for Prostate Cancer: A Case Series
Toapichattrakul P, Muangwong P, Kongsa A, et al. | Cureus Competition | 2025
3089: Early Report on Acute and Late Toxicity of Helical Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost for Cancer Prostate
Cheikh Tayeb et al. | ESTRO | 2025
2849: Bladder Preservation Using Immunotherapy and Radiotherapy in Muscle-Invasive Bladder Cancer
Isabela Gaztelu et al. | ESTRO | 2025
447: IMRT by TomoTherapy with Concurrent Weekly Cisplatin Followed by Brachytherapy HDR in Locally Advance Cervical Cancer (Prospective Study)
Sofiane Mellouk et al. | ESTRO | 2025
3898: One-day Urethral-sparing, HDR-like, Prostate Cancer Robotic SBRT: Preliminary Results of the PRO-FAST Trial
Andrei Fodor et al. | ESTRO | 2025
3734: Analysis and Comparison of CyberKnife MLC Collimator Versus IRIS Collimator in Prostate SBRT
Gaetano Gagliardo et al. | ESTRO | 2025
3492: CyberKnife UH-SBRT for Localized Prostate Cancer and DIL: Preliminary Report of Acute and Late Toxicity of the PRO-SPEED Trial (NCT06331013)
Giovanni Carlo Mazzola et al. | ESTRO | 2025
2803: Comparison of Radiotherapy with CyberKnife or Low Dose Rate Brachytherapy of Low-intermediate Risk Prostate Cancer Patients After Six-year Follow-up
Péter Ágoston et al. | ESTRO | 2025
